Area of research
Organic Chemistry · Molecular Biology
Research interest
Research interests include Catalytic C–H Functionalization Methods, Radical Photochemical Reactions, Sulfur-Based Synthesis Techniques, and Synthesis and Catalytic Reactions.
Comparable perioperative performance between three robotic system for robot-assisted partial nephrectomy to treat early renal cancer
Pt Sub‐Nanoclusters on ZIF‐Derived Ultrafine Cd <sub> <i>x</i> </sub> Zn <sub> 1− <i>x</i> </sub> S Solid Solution: High‐Performance Photoreforming Lactic Acid to H <sub>2</sub> and Value‐Added Chemicals
An Aggregation‐Induced Emission Fluorescent Probe for Detecting β‐Amyloid Plaques
Selective Separation of U(VI) from Pu(IV) by 2,9-Diamide-1,10-phenanthroline Ligands at High Acidity: Extraction and Coordination Chemistry
Photo-induced deep aerobic oxidation of alkyl aromatics
Environmentally persistent free radicals mediated removal of Cr(VI) from highly saline water by corn straw biochars
Extreme low dose of 5-fluorouracil reverses MDR in cancer by sensitizing cancer associated fibroblasts and down-regulating P-gp
The Prodomain-Containing BMP9 Produced from a Stable Line Effectively Regulates the Differentiation of Mesenchymal Stem Cells
New mouse xenograft model modulated by tumor-associated fibroblasts for human multi-drug resistance in cancer
Molecular-Matched Materials for Anticancer Drug Delivery And Imaging
WITHDRAWN: Programmed hydrolysis in designing paclitaxel prodrug for nanocarrier assembly
Combinational Delivery of Hydrophobic and Hydrophilic Anticancer Drugs in Single Nanoemulsions To Treat MDR in Cancer
Shape-Controlled Paclitaxel Nanoparticles with Multiple Morphologies: Rod-Shaped, Worm-Like, Spherical, and Fingerprint-Like
Theranostic Nanoemulsions: Codelivery of Hydrophobic Drug and Hydrophilic Imaging Probe for Cancer Therapy and Imaging
Vitamin E reverses multidrug resistance in vitro and in vivo
Key Structure of Brij for Overcoming Multidrug Resistance in Cancer
Multifunctional Nanoparticles Based on a Single-Molecule Modification for the Treatment of Drug-Resistant Cancer